Lviv clinical bulletin 2015, 2(10)-3(11): 15-20

https://doi.org/10.25040/lkv2015.023.015

Fibromyalgia as a Modifying Factor of Clinical Course of Rheumatoid Arthritis

Posted onAuthorAdminЗалишити коментар / Leave a comment

L. Perebetyuk 

National Pirogov Memorial Medical University, Vinnytsya

Introduction. Rheumatoid arthritis (RA) is one of the most common inflammatory joint disease, with a progressing severity and high disability. It is often combined with fibromyalgia (FM), which can modify its course. The prevalence of primary FM among adults is on average 2.0-3.0 %, with prevalence of females and peak age of 55-64 years. In recent years, the principles of diagnosis of FM have been revised, along with the traditional criteria ACR1990 the modified criteria mACR2010 were proposed, but there is practically no experience with their use in patients with RA.

Aim. To find out the clinical features of patients with RA associated with FM, and the possible association of the course of the disease with FM markers according to the criteria ACR1990 and mACR2010.

Materials and methods. 125 patients (100.0 % female) with RA were included in the study. In 46 of them RA was associated with FM. Mean age of the patients under investigation was 49.6 ± 12.8 years. The diagnosis RA was established by ACR/EULAR-2010 criteria, the diagnosis FM was established regarding ACR1990 and modified ACR2010 criteria. RA activity was evaluated by DAS28 and CDAI, functional status – by HAQ.

The diagnosis of FM was given in the case of detecting at least 11 (out of 18) specific sensory points (CP ≥ 11) and 13 (from 31) on the scale of fibromyalgia (SF ≥ 13) in patients with RA. Specific CPs were determined by pressing with a finger at them with a force of 4 kg/cm2 (to the effect of whitening of the nail bed of the researcher) and were considered positive if the patient felt pain.

Results and discussion. By the evaluation of clinical features of patients in which the rheumatoid arthritis (RA) was associated with fibromyalgia (FM) it was found that these patients had a higher disease activity by DAS28 and CDAI (OR = 13.3, 95% CI 4.41, 40.3). Significant violations of the physical function (HAQ>2) were found in 40.0 % of RA patients associated with FM, and in 19.0 % of patients with isolated RA. In the presence of FM in patients with RA the difference between the number of tender and swollen joints was 3.16 times higher and significantly correlated with the markers of the central sensitization (number of tender points fibromyalgianess scale). FM frequency was higher among the patients with seronegative RA (OR = 2.90, 95% CI 1.36, 6.21).

Phenotypic features of patients with RA suggest the need for modification of diagnostic and therapeutic measures in patients with a fibromyalgic variant of the disease.

Conclusions. FM is an independent factor that modifies the clinical course of the RA, causes an increased disease activity by DAS28 and CDAI, significantly impairs physical function for the RA patients.

References

  1. Bortkevych A, Bilyavskaya Y. Clinical and diagnostic value of antibodies to cyclic citrulinated peptide in patients with different duration of rheumatoid arthritis. Ukrainian Journal of Rheumatology. 2008;3:58-64. (Ukrainian).
  2. Kovalenko V, Golovach I, Bortkevych A. Personification of treatment of rheumatoid arthritis: direction to achievingof optimal results. Ukrainian Journal of Rheumatology. 2011;3:5-15. (Russian).
  3. Neiko E, Yatsyshyn R, Shtefyuk A. Rheumatoid arthritis: a modern view on the problem. Ukrainian Journal of Rheumatology. 2009;2:35-39. (Ukrainian).
  4. Sapon D. Problems of Diagnosis and treatment of patients with fibromyalgia. Archives of Psychiatry. 2012;19(4):129-135. (Russian).
  5. Joharatnam N, McWilliams DF, Wilson D, Wheeler M, Pande I, Walsh DA. A cross-sectional study of pain sensitivity, disease-activity assessment, mental health, and fibromyalgia status in rheumatoid arthritis. Arthritis Res Ther. 2015;17(1):11. https://doi.org/10.1186/s13075-015-0525-5
  6. Andersson ML, Svensson B, Bergman S. Chronic widespread pain in patients with rheumatoid arthritis and the relation between pain and disease activity measures over the first 5 years. J Rheumatol. 2013;40(12):1977–1985. https://doi.org/10.3899/jrheum.130493
  7. Ranzolin A, Brenol JC, Bredemeier M, Guarienti J, Rizzatti M, Feldman D et al. Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis. Arthritis Rheum. 2009;61(6):794–800. https://doi.org/10.1002/art.24430
  8. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RS et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011;38(6): 1113–1122. https://doi.org/10.3899/jrheum.100594
  9. Kapoor SR, Hider SL, Brownfield A, Mattey DL, Packham JC. Fibromyalgia in patients with rheumatoid arthritis: driven by depression or joint damage? Clin Exp Rheumatol. 2011;29(6 Suppl 69):88-91.
  10. Dhir V, Lawrence A, Aggarwal A, Misra R. Fibromyalgia is common and adversely affects pain and fatigue perception in North Indian patients with rheumatoid arthritis. J Rheumatol. 2009;36(11):2443-2448. https://doi.org/10.3899/jrheum.090157
  11. Pollard LC, Kingsley GH, Choy EH, Scott DL. Fibromyalgic rheumatoid arthritis and disease assessment. Rheumatology (Oxford). 2010;49(5):924-928. https://doi.org/10.1093/rheumatology/kep458
  12. Gabriel ShE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther. 2009; 11(3):229. https://doi.org/10.1186/ar2669
  13. Lee YC, Lu B, Boire G, Haraoui BP, Hitchon CA, Pope JE et al. Incidence and predictors of secondary fibromyalgia in an early arthritis cohort. Ann Rheum Dis. 2013;72(6):949-954. https://doi.org/10.1136/annrheumdis-2012-201506
  14. Marcus DA, Deodhar A. Fibromyalgia Definition and Epidemiology. A Practical Clinical Guide. New-York: Springer-Verlag, 2011. р. 9-21.
  15. Menzies V, Lyon DE, Elswick RK, Montpetit AJ, McCain NL. Psychoneuroimmunological relationships in women with fibromyalgia. Biol Res Nurs. 2013;15(2):219-225. https://doi.org/10.1177/1099800411424204
  16. Roig VD, Hoces OC. Effect of the coexistence of fibromyalgia in the DAS28 index in women with rheumatoid arthritis. Reumatol Clin. 2008;4(3):96-99.
  17. Ton E, Bakker MF, Verstappen SM, Ter Borg EJ, van Albada-Kuipers IA, Schenk Y et al. Utrecht Rheumatoid Arthritis Cohort Study Group. Look beyond the disease activity score of 28 joints (DAS28): tender points influence the DAS28 in patients with rheumatoid arthritis. J Rheumatol. 2012;39(1):22-27. https://doi.org/10.3899/jrheum.110072
  18. Yunus MB. The prevalence of fibromyalgia in other chronic pain conditions. Pain Res Treat. 2012;2012:584573. https://doi.org/10.1155/2012/584573
  19. Zammurrad S, Munir W, Farooqi A. Disease activity score in rheumatoid arthritis with or without secondary fibromyalgia. J Coll Physicians Surg Pak. 2013;23(6):413-417.